Simplex Trading
RANI icon

Simplex Trading’s Rani Therapeutics RANI Stock Holding History

Simplex Trading’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.9K Sell
5,136
-4,965
-49% -$4.4K ﹤0.01% 8311
2026
Q1 		$7.42K Buy
+10,101
New +$12.9K ﹤0.01% 7609
2025
Q4 		– Sell
-819
Closed -$1.24K – 9798
2025
Q3 		$0 Buy
+819
New +$427 ﹤0.01% 9871
2024
Q4 		– Sell
-2,835
Closed -$5.96K – 9422
2024
Q3 		$6K Buy
2,835
+1,353
+91% +$3.88K ﹤0.01% 7546
2024
Q2 		$5K Buy
1,482
+118
+9% +$611 ﹤0.01% 7895
2024
Q1 		$4K Sell
1,364
-7,772
-85% -$26.7K ﹤0.01% 8153
2023
Q4 		$30K Buy
9,136
+7,893
+635% +$18.3K ﹤0.01% 6564
2023
Q3 		$2K Sell
1,243
-308
-20% -$1.18K ﹤0.01% 8146
2023
Q2 		$6K Buy
1,551
+1,206
+350% +$5.6K ﹤0.01% 7822
2023
Q1 		$1K Buy
345
+45
+15% +$271 ﹤0.01% 8753
2022
Q4 		$1K Buy
300
+78
+35% +$569 ﹤0.01% 8898
2022
Q3 		$2K Buy
+222
New +$2.35K ﹤0.01% 9337

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Simplex Trading's RANI Position: Q2 2026 in Review

Simplex Trading reduced its Rani Therapeutics (RANI) stake by 49% in Q2 2026, selling an estimated $4.4K and leaving 5,136 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #8311.

Simplex Trading first reported a position in RANI in Q3 2022 and has held it in 12 quarters since. The position peaked at $30K in Q4 2023. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • Simplex Trading held 5,136 shares of Rani Therapeutics worth $3.9K as of Q2 2026.
  • Simplex Trading sold 4,965 Rani Therapeutics shares in Q2 2026, an estimated $4.4K.
  • Rani Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8311 holding.
  • Simplex Trading first reported a position in Rani Therapeutics in Q3 2022 and has held it in 12 quarters since.
  • Simplex Trading's Rani Therapeutics position peaked at $30K in Q4 2023.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.